Scholarly Index
Nobuhisa Mizuki
Yokohama City University; 10,772 total citations; 383 total publications; best world rank #63
Yokohama City University
10,772Total citations
383Total publications
55H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Ocular Diseases and Behçet’s Syndrome | Lifetime | 81 | JP 3 | 99.06 |
| Systemic Lupus Erythematosus Research | Lifetime | 719 | JP 28 | 97.93 |
| Autoimmune and Inflammatory Disorders Research | Lifetime | 506 | JP 17 | 96.92 |
| Otitis Media and Relapsing Polychondritis | Lifetime | 112 | JP 3 | 96.47 |
| Inflammasome and immune disorders | Lifetime | 696 | JP 42 | 94.37 |
| Sarcoidosis and Beryllium Toxicity Research | Lifetime | 720 | JP 81 | 91.86 |
| Nasolacrimal Duct Obstruction Treatments | Lifetime | 427 | JP 17 | 77.21 |
| Ocular Diseases and Behçet’s Syndrome | 2021-2025 | 113 | JP 7 | 95.12 |
| Intraocular Surgery and Lenses | 2021-2025 | 175 | JP 7 | 94.31 |
| Corneal surgery and disorders | 2021-2025 | 488 | JP 23 | 91.89 |
| Ocular Surface and Contact Lens | 2021-2025 | 416 | JP 16 | 90.33 |
| Retinal and Optic Conditions | 2021-2025 | 861 | JP 56 | 85.47 |
| Ocular Infections and Treatments | 2021-2025 | 267 | JP 4 | 81.66 |
| Ophthalmology and Visual Impairment Studies | 2021-2025 | 786 | JP 23 | 83.06 |
| Nasolacrimal Duct Obstruction Treatments | 2021-2025 | 63 | JP 6 | 71.56 |